This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.The post New Approaches to Adherence and Prevention of Dropouts: the Digital Era of Patient Engagement in Cardiometabolic Trials appeared first on Clinical ink.
Clinical Ink is a Pennsylvania-based clinical trial platform that provides solutions such as data management and patient engagement for the healthcare sector.